Earnings History Data for Praxis Precision Medicines, Inc. (PRAX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Praxis Precision Medicines, Inc.

Praxis Precision Medicines Inc. is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders characterized by neuronal imbalance. Praxis Precision Medicines Inc. is based in CAMBRIDGE, Mass.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
06-11-2024	PM		PRAX	Praxis Precision Medicines, Inc.	1,240	-2.75	-2.01	-2.70	Praxis Precision Medicines GAAP EPS of -$2.75 misses by $0.76, revenue of $0.3M in-line [11/6/2024 7:34 AM]	72.35	-0.38 (-0.52%)	68.48	-4.25 (-5.84%)	13.01 - 75.87	1,374,629	170,000	1,803
Praxis Precision Medicines GAAP EPS of -$2.75 misses by $0.76, revenue of $0.3M in-line [11/6/2024 7:34 AM] Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2024 Financial Results [2024-11-06 07:30AM] Praxis Precision Medicines, Inc. (PRAX) Reports Q3 Loss, Misses Revenue Estimates [2024-11-06 08:45AM]
13-08-2024	PM		PRAX	Praxis Precision Medicines	905.00	-1.74	-2.38	0.00	Praxis Precision Medicines GAAP EPS of -$1.74 beats by $0.57, revenue of $0.36M misses by $0.47M [8/13/2024 7:04 AM]	51.65	-0.17 (-0.33%)	0.0	0.0 (0.00%)	13.01 - 67.21	197,379	250,000	0
Praxis Precision Medicines GAAP EPS of -$1.74 beats by $0.57, revenue of $0.36M misses by $0.47M [8/13/2024 7:04 AM]
13-05-2024	PM		PRAX	Praxis Precision Medicines, Inc.	829.34	-2.84	-2.01	-10.64	Praxis Precision Medicines GAAP EPS of -$2.84 misses by $0.75, revenue of $0.43M misses by $1.33M [5/13/2024 8:48 AM]	45.56	-3.22 (-6.60%)	0.0	0.0 (0.00%)	12.45 - 67.21	341,546	160,000	0
Praxis Precision Medicines GAAP EPS of -$2.84 misses by $0.75, revenue of $0.43M misses by $1.33M [5/13/2024 8:48 AM]
05-03-2024	??		PRAX	Praxis Precision Medicines, Inc.	424.56	-2.97	-3.15	-13.04	Praxis Precision Medicines GAAP EPS of -$2.97 misses by $0.92, revenue of $0.52M misses by $0.52M [3/6/2024 1:06 PM]	56.16	-2.00 (-3.45%)	58.16	0.0 (0.00%)	11.85 - 59.97	92,121	110,000	237
Praxis Precision Medicines GAAP EPS of -$2.97 misses by $0.92, revenue of $0.52M misses by $0.52M [3/6/2024 1:06 PM]
07-11-2023	PM		PRAX	Praxis Precision Medicines	144.00	-0.18	-0.35	0.00	Praxis Precision Medicines GAAP EPS of -$0.18 beats by $0.17, revenue of $0.47M [11/7/2023 8:24 AM]	1.06	0.07 (7.53%)	1.09	0.10 (10.56%)	0.79 - 5.25	245,963	490,000	7,296
Praxis Precision Medicines GAAP EPS of -$0.18 beats by $0.17, revenue of $0.47M [11/7/2023 8:24 AM]
09-08-2023	PM		PRAX	Praxis Precision Medicines	59.00	-0.49	-0.66	0.00	Praxis Precision Medicines GAAP EPS of -$0.49 beats by $0.17, revenue of $0.78M [8/9/2023 12:18 PM]	0.9950	0.03 (3.00%)	0.97	0.0 (0.00%)	0.79 - 5.25	353,459	340,000	2,259
Praxis Precision Medicines GAAP EPS of -$0.49 beats by $0.17, revenue of $0.78M [8/9/2023 12:18 PM]
11-05-2023	PM		PRAX	Praxis Precision Medicines	61.00	-0.71	-0.75	0.00	Praxis Precision Medicines GAAP EPS of -$0.71, revenue of $0.68M [5/11/2023 2:05 PM]	1.08	0.01 (1.40%)	1.08	0.01 (0.93%)	0.79 - 13.33	1,670,898	510,000	1,647,655
Praxis releases promising phase 1 results on epilepsy candidate [5/11/2023 9:30 AM] Praxis Precision Medicines GAAP EPS of -$0.71, revenue of $0.68M [5/11/2023 2:05 PM]
07-02-2023	PM		PRAX	Praxis Precision Medicines	219.00	-0.87	-0.73	0.00	Praxis Precision Medicines GAAP EPS of -$0.87 misses by $0.08 [2/7/2023 9:02 AM]	4.47	-0.06 (-1.21%)	4.45	-0.08 (-1.77%)	1.48 - 14.71	1,329,368	1,090,000	419
Praxis Precision Medicines GAAP EPS of -$0.87 misses by $0.08 [2/7/2023 9:02 AM]
08-08-2022	AH	4:00 PM ET (Aug 8)	PRAX	Praxis Precision Medicines	151.00	-1.32	-1.30	0.00	Praxis Precision Medicines GAAP EPS of -$1.32 misses by $0.02 [8/8/2022 5:24 PM]	4.00	0.07 (1.78%)	3.88	-0.05 (-1.27%)	1.63 - 23.56	561,051	720,000	1,412
Praxis Precision Medicines GAAP EPS of -$1.32 misses by $0.02 [8/8/2022 5:24 PM]
09-05-2022	AH	After the close (May 9)	PRAX	Praxis Precision Medicines, Inc.	369.97	-1.51	-1.29	-0.71	Praxis Precision Medicines GAAP EPS of -$1.51 misses by $0.21 [5/9/2022 4:53 PM]	9.21	1.82 (24.63%)	7.73	0.34 (4.60%)	7.25 - 27.51	653,844	245,893	4,587
Praxis Precision Medicines GAAP EPS of -$1.51 misses by $0.21 [5/9/2022 4:53 PM] Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2022 Financial Results [May-09-22 04:01PM] Praxis Precision Medicines Reports Positive Topline Results from PRAX-944 Phase 2a Study in Essential Tremor Patients [May-09-22 04:01PM] Praxis' PRAX-944 Shows Promising Action In Essential Tremor Patients [May-10-22 08:22AM]
28-02-2022	PM	7:00 AM ET (Feb 28)	PRAX	Praxis Precision Medicines	616.00	-1.30	-1.08	0.00	Praxis Precision Medicines GAAP EPS of -$1.30 [2/28/2022 6:05 AM]	13.02	-0.31 (-2.33%)	13.33	0.0 (0.00%)	12.23 - 50.20	192,349	180,000	1,280
Praxis Precision Medicines GAAP EPS of -$1.30 [2/28/2022 6:05 AM] Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results [Feb-28-22 06:00AM]
03-11-2021	PM	8:00 AM ET (Nov 3)	PRAX	Praxis Precision Medicines, Inc.	971.60	-1.00	-0.93	-12.10	Praxis Precision Medicines EPS misses by $0.07 [11/3/2021 7:42 AM]	21.88	0.18 (0.83%)	21.70	0.0 (0.00%)	12.71 - 60.95	307,653	140,000	1,057
Praxis Precision Medicines EPS misses by $0.07 [11/3/2021 7:42 AM] Praxis Precision Medicines files for mixed shelf offering [11/3/2021 6:18 PM] Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2021 Financial Results [Nov-03-21 07:00AM]
16-08-2021	PM		PRAX	Praxis Precision Medicines, Inc.	537.00	-0.88	-0.68	0.00	Praxis Precision Medicines reports Q2 results [8/16/2021 8:39 AM]	13.11	-0.69 (-5.00%)	14.10	0.30 (2.17%)	12.75 - 60.95	200,294	140,000	5,868
Praxis Precision plans to advance PRAX-114 after phase 2a trial results [8/16/2021 8:11 AM] Praxis Precision Medicines reports Q2 results [8/16/2021 8:39 AM] Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2021 Financial Results [Aug-16-21 08:00AM] Praxis Precision Medicines Reports PRAX-114 Perimenopausal Depression (PMD) Phase 2a Proof-of-Concept Trial Results and Announces Plans to Advance to Phase 2b Study in Women with Menopausal and Mood Symptoms [Aug-16-21 07:55AM]
11-05-2021	PM		PRAX	Praxis Precision Medicines, Inc.	1,084	-0.71	-0.74	0.00	Praxis Precision Medicines EPS beats by $0.03 [5/11/2021 8:59 AM]	25.85	-0.01 (-0.04%)	25.86	0.0 (0.00%)	23.90 - 60.95	165,967	200,000	1,514
Praxis Precision Medicines EPS beats by $0.03 [5/11/2021 8:59 AM] Praxis Precision Medicines proposes 4M public offering [5/11/2021 4:29 PM] Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2021 Financial Results [May-11-21 08:00AM] Praxis Precision Medicines Announces Proposed Public Offering of Common Stock [May-11-21 04:22PM]